Drug hypersensitivity: pharmacogenetics and clinical syndromes.
Drug hypersensitivity: pharmacogenetics and clinical syndromes.
复制标题
DOI:
10.1016/j.jaci.2010.11.046
复制
发表时间:
2011-03
期刊:
影响因子:
--
通讯作者:
Mallal SA
中科院分区:
文献类型:
--
作者:
Phillips EJ;Chung WH;Mockenhaupt M;Roujeau JC;Mallal SA
Severe cutaneous adverse reactions (SCARs) include syndromes such as drug reaction, eosinophilia and systemic symptoms (DRESS) or drug-induced hypersensitivity syndrome (DIHS) and Stevens-Johnson Syndrome/Toxic epidermal necrolysis (SJS/TEN). An important advance has been the discovery of associations between HLA alleles and many of these syndromes including abacavir hypersensitivity reaction, allopurinol DRESS/DIHS and SJS/TEN and SJS/TEN associated with aromatic amine anticonvulsants. These HLA associations have created the promise for prevention through screening and have additionally shed further light on the immunopathogenesis of SCARs. The roll-out of HLA-B*5701 into routine clinical practice as a genetic screening test to prevent abacavir hypersensitivity provides a translational roadmap for other drugs. Numerous hurdles exist in the widespread translation of several other drugs such as carbamazepine where the positive predictive value of HLA-B*1502 is low and the negative predictive value of HLA-B*1502 for SJS/TEN may not be 100% in all ethnic groups. International collaborative consortia have been formed with the goal of developing phenotype standardization and undertaking HLA and genome-wide analyses in diverse populations with these syndromes.
登录
查看更多内容
影响因子:
3.8
作者:
Littera, Roberto;Carcassi, Carlo;Manconi, Paolo Emilio
通讯作者:
Manconi, Paolo Emilio
DOI:
10.1073/pnas.0409500102
发表时间:
2005-03-15
影响因子:
11.1
作者:
Hung, SL;Chung, WH;Chen, YT
通讯作者:
Chen, YT
影响因子:
2.8
作者:
Gueant-Rodriguez, R-M;Gueant, J-L;Romano, A.
通讯作者:
Romano, A.
影响因子:
13.8
作者:
Halevy, Sitna;Ghislain, Pierre-Dominique;Roujeau, Jean-Claude
通讯作者:
Roujeau, Jean-Claude
影响因子:
82.9
作者:
Chung, Wen-Hung;Hung, Shuen-Iu;Chen, Yuan-Tsong
通讯作者:
Chen, Yuan-Tsong